NCT00217542
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Yale University New Haven, Connecticut, United States
Clinical trial condition
Stage IV Renal Cell Cancer
Explore clinical trials studying Stage IV Renal Cell Cancer. Study availability and eligibility vary by location and protocol.
63 public trials
1 recruiting study
Stage IV Renal Cell Cancer trial results
Completed
Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00112476
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
NCT00182702
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
Completed
Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT00101114
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
NCT00060307
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00032188
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT00006486
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
Completed
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
NCT01158534
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States